[Elsevier] Efficacy of Initiation of Semaglutide versus SGLT2 inhibitors in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Multicenter Propensity-Matched Real-World Study

hisab Post time 1 hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-06-28 16:08

Reward10points

journal：Endocrine Practice

Authors：Ibrahim Khalil; Pallab Sarker; Md. Imran Hossain; Anika Chowdhury; Aizaz Anwar Khalid; Ananna Saha; Joydip Chowdhury; Mst. Mahmuda Akter; Sunjida Amin Promi; Md Abu Sayed; Mohd Turzo Rahman; A.B.M. Kamrul-Hasan

Published date：2026-6-

DOI：10.1016/j.eprac.2026.06.004

PDF link：https://www.sciencedirect.com/sc ... 530891X26010384/pdf

Article link：https://doi.org/10.1016/j.eprac.2026.06.004

Article Source：Elsevier BV。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report